CDC Vaccine Advisory Panel Delays Key Hepatitis B Vote Amid MMRV Guidance Changes

TL;DR
Vaccine advisers to the CDC delayed a decision on changing the timing of the hepatitis B vaccine for newborns, voting to wait until at least one month old instead of at birth, and also voted on the use of the combined MMRV vaccine, reflecting ongoing debates and uncertainties in vaccine policy.
- In chaotic start to meeting, CDC vaccine advisers delay hepatitis B vaccine vote, cast new MMRV vaccine vote CNN
- RFK Jr vaccine panel delays pivotal hepatitis B vote in shake-up USA Today
- CDC advisers punt on hepatitis B vaccine vote, after changing guidance on MMRV NPR
- CDC advisory panel recommends restricting access to the MMRV vaccine NBC News
- Kennedy’s vaccine panel votes to delay hepatitis B vote Politico
Want the full story? Read the original reporting
Read on CNN